These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 35061305)
21. The nuclear phosphatase SCP4 regulates FoxO transcription factors during muscle wasting in chronic kidney disease. Liu X; Yu R; Sun L; Garibotto G; Lin X; Wang Y; Thomas SS; Li R; Hu Z Kidney Int; 2017 Aug; 92(2):336-348. PubMed ID: 28506762 [TBL] [Abstract][Full Text] [Related]
22. Posttranslational modifications control FoxO3 activity during denervation. Bertaggia E; Coletto L; Sandri M Am J Physiol Cell Physiol; 2012 Feb; 302(3):C587-96. PubMed ID: 22094330 [TBL] [Abstract][Full Text] [Related]
23. FOXO1 regulates the expression of 4E-BP1 and inhibits mTOR signaling in mammalian skeletal muscle. Southgate RJ; Neill B; Prelovsek O; El-Osta A; Kamei Y; Miura S; Ezaki O; McLoughlin TJ; Zhang W; Unterman TG; Febbraio MA J Biol Chem; 2007 Jul; 282(29):21176-86. PubMed ID: 17510058 [TBL] [Abstract][Full Text] [Related]
24. Suppression of Fatty Acid and Triglyceride Synthesis by the Flavonoid Orientin through Decrease of C/EBPδ Expression and Inhibition of PI3K/Akt-FOXO1 Signaling in Adipocytes. Nagai S; Matsumoto C; Shibano M; Fujimori K Nutrients; 2018 Jan; 10(2):. PubMed ID: 29373533 [TBL] [Abstract][Full Text] [Related]
25. Genome-wide identification of FoxO-dependent gene networks in skeletal muscle during C26 cancer cachexia. Judge SM; Wu CL; Beharry AW; Roberts BM; Ferreira LF; Kandarian SC; Judge AR BMC Cancer; 2014 Dec; 14():997. PubMed ID: 25539728 [TBL] [Abstract][Full Text] [Related]
26. C/EBPβ mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting. Zhang G; Jin B; Li YP EMBO J; 2011 Aug; 30(20):4323-35. PubMed ID: 21847090 [TBL] [Abstract][Full Text] [Related]
27. Involvement of the FoxO1/MuRF1/Atrogin-1 Signaling Pathway in the Oxidative Stress-Induced Atrophy of Cultured Chronic Obstructive Pulmonary Disease Myotubes. Pomiès P; Blaquière M; Maury J; Mercier J; Gouzi F; Hayot M PLoS One; 2016; 11(8):e0160092. PubMed ID: 27526027 [TBL] [Abstract][Full Text] [Related]
28. p53 and ATF4 mediate distinct and additive pathways to skeletal muscle atrophy during limb immobilization. Fox DK; Ebert SM; Bongers KS; Dyle MC; Bullard SA; Dierdorff JM; Kunkel SD; Adams CM Am J Physiol Endocrinol Metab; 2014 Aug; 307(3):E245-61. PubMed ID: 24895282 [TBL] [Abstract][Full Text] [Related]
30. Sulforaphane prevents dexamethasone-induced muscle atrophy via regulation of the Akt/Foxo1 axis in C2C12 myotubes. Son YH; Jang EJ; Kim YW; Lee JH Biomed Pharmacother; 2017 Nov; 95():1486-1492. PubMed ID: 28946211 [TBL] [Abstract][Full Text] [Related]
31. Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasome. Sandri M Int J Biochem Cell Biol; 2013 Oct; 45(10):2121-9. PubMed ID: 23665154 [TBL] [Abstract][Full Text] [Related]
32. Skeletal muscle denervation causes skeletal muscle atrophy through a pathway that involves both Gadd45a and HDAC4. Bongers KS; Fox DK; Ebert SM; Kunkel SD; Dyle MC; Bullard SA; Dierdorff JM; Adams CM Am J Physiol Endocrinol Metab; 2013 Oct; 305(7):E907-15. PubMed ID: 23941879 [TBL] [Abstract][Full Text] [Related]